Industry: Healthcare
Published Date: August-2024
Format: PPT*, PDF, EXCEL
Delivery Timelines: Contact Sales
Number of Pages: 219
Report ID: PMRREP34578
1. Executive Summary
1.1. Global Liver Cirrhosis Treatment Market Snapshot, 2024 and 2031
1.2. Market Opportunity Assessment, 2024 - 2031, US$ Bn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations
2. Market Overview
2.1. Market Scope and Definition
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Opportunity
2.2.4. Challenges
2.2.5. Key Trends
2.3. Macro-Economic Factors
2.3.1. Global Sectorial Outlook
2.3.2. Global GDP Growth Outlook
2.3.3. Global Healthcare Spending Outlook
2.4. COVID-19 Impact Analysis
2.5. Forecast Factors - Relevance and Impact
3. Value Added Insights
3.1. Product Adoption Analysis
3.2. Epidemiology - Prevalence and Incidence of Liver Cirrhosis
3.3. Technology Assessment
3.4. Regulatory Landscape
3.5. Value Chain Analysis
3.5.1. List of Distribution Channel
3.5.2. List of End User (Industry)
3.6. Key Deals and Mergers
3.7. PESTLE Analysis
3.8. Porter's Five Force Analysis
4. Global Liver Cirrhosis Treatment Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
4.1. Key Highlights
4.1.1. Market Size (US$ Bn) and Y-o-Y Growth
4.1.2. Absolute $ Opportunity
4.2. Market Size (US$ Bn) Analysis and Forecast
4.2.1. Historical Market Size (US$ Bn) Analysis, 2018-2022
4.2.2. Current Market Size (US$ Bn) Analysis and Forecast, 2023-2031
4.3. Global Liver Cirrhosis Treatment Market Outlook: Treatment
4.3.1. Introduction / Key Findings
4.3.2. Historical Market Size (US$ Bn) Analysis, By Treatment, 2018 - 2022
4.3.3. Current Market Size (US$ Bn) Analysis and Forecast, By Treatment, 2023 - 2031
4.3.3.1. Antibiotics
4.3.3.2. Immunosuppressants
4.3.3.3. Others
4.4. Market Attractiveness Analysis: Treatment
4.5. Global Liver Cirrhosis Treatment Market Outlook: End-use
4.5.1. Introduction / Key Findings
4.5.2. Historical Market Size (US$ Bn) Analysis, By End-use, 2018 - 2022
4.5.3. Current Market Size (US$ Bn) Analysis and Forecast, By End-use, 2023 - 2031
4.5.3.1. Hospitals
4.5.3.2. Clinics
4.5.3.3. Pharmaceutical companies
4.5.3.4. Research institutions
4.6. Market Attractiveness Analysis: End-use
5. Global Liver Cirrhosis Treatment Market Outlook: Region
5.1. Key Highlights
5.2. Historical Market Size (US$ Bn) Analysis, By Region, 2018 - 2022
5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Region, 2023 - 2031
5.3.1. North America
5.3.2. Europe
5.3.3. East Asia
5.3.4. South Asia and Oceania
5.3.5. Latin America
5.3.6. Middle East & Africa
5.4. Market Attractiveness Analysis: Region
6. North America Liver Cirrhosis Treatment Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
6.1. Key Highlights
6.2. Historical Market Size (US$ Bn) Analysis, By Market, 2018 - 2022
6.2.1. By Country
6.2.2. By Treatment
6.2.3. By End-use
6.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2023 - 2031
6.3.1. U.S.
6.3.2. Canada
6.4. Current Market Size (US$ Bn) Analysis and Forecast, By Treatment, 2023 - 2031
6.4.1. Antibiotics
6.4.2. Immunosuppressants
6.4.3. Others
6.5. Current Market Size (US$ Bn) Analysis and Forecast, By End-use, 2023 - 2031
6.5.1. Hospitals
6.5.2. Clinics
6.5.3. Pharmaceutical companies
6.5.4. Research institutions
6.6. Market Attractiveness Analysis
7. Europe Liver Cirrhosis Treatment Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
7.1. Key Highlights
7.2. Historical Market Size (US$ Bn) Analysis, By Market, 2018 - 2022
7.2.1. By Country
7.2.2. By Treatment
7.2.3. By End-use
7.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2023 - 2031
7.3.1. Germany
7.3.2. France
7.3.3. U.K.
7.3.4. Italy
7.3.5. Spain
7.3.6. Russia
7.3.7. Türkiye
7.3.8. Rest of Europe
7.4. Current Market Size (US$ Bn) Analysis and Forecast, By Treatment, 2023 - 2031
7.4.1. Antibiotics
7.4.2. Immunosuppressants
7.4.3. Others
7.5. Current Market Size (US$ Bn) Analysis and Forecast, By End-use, 2023 - 2031
7.5.1. Hospitals
7.5.2. Clinics
7.5.3. Pharmaceutical companies
7.5.4. Research institutions
7.6. Market Attractiveness Analysis
8. East Asia Liver Cirrhosis Treatment Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
8.1. Key Highlights
8.2. Historical Market Size (US$ Bn) Analysis, By Market, 2018 - 2022
8.2.1. By Country
8.2.2. By Treatment
8.2.3. By End-use
8.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2023 - 2031
8.3.1. China
8.3.2. Japan
8.3.3. South Korea
8.4. Current Market Size (US$ Bn) Analysis and Forecast, By Treatment, 2023 - 2031
8.4.1. Antibiotics
8.4.2. Immunosuppressants
8.4.3. Others
8.5. Current Market Size (US$ Bn) Analysis and Forecast, By End-use, 2023 - 2031
8.5.1. Hospitals
8.5.2. Clinics
8.5.3. Pharmaceutical companies
8.5.4. Research institutions
8.6. Market Attractiveness Analysis
9. South Asia & Oceania Liver Cirrhosis Treatment Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
9.1. Key Highlights
9.2. Historical Market Size (US$ Bn) Analysis, By Market, 2018 - 2022
9.2.1. By Country
9.2.2. By Treatment
9.2.3. By End-use
9.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2023 - 2031
9.3.1. India
9.3.2. Southeast Asia
9.3.3. ANZ
9.3.4. Rest of South Asia & Oceania
9.4. Current Market Size (US$ Bn) Analysis and Forecast, By Treatment, 2023 - 2031
9.4.1. Antibiotics
9.4.2. Immunosuppressants
9.4.3. Others
9.5. Current Market Size (US$ Bn) Analysis and Forecast, By End-use, 2023 - 2031
9.5.1. Hospitals
9.5.2. Clinics
9.5.3. Pharmaceutical companies
9.5.4. Research institutions
9.6. Market Attractiveness Analysis
10. Latin America Liver Cirrhosis Treatment Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
10.1. Key Highlights
10.2. Historical Market Size (US$ Bn) Analysis, By Market, 2018 - 2022
10.2.1. By Country
10.2.2. By Treatment
10.2.3. By End-use
10.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2023 - 2031
10.3.1. Brazil
10.3.2. Mexico
10.3.3. Rest of Latin America
10.4. Current Market Size (US$ Bn) Analysis and Forecast, By Treatment, 2023 - 2031
10.4.1. Antibiotics
10.4.2. Immunosuppressants
10.4.3. Others
10.5. Current Market Size (US$ Bn) Analysis and Forecast, By End-use, 2023 - 2031
10.5.1. Hospitals
10.5.2. Clinics
10.5.3. Pharmaceutical companies
10.5.4. Research institutions
10.6. Market Attractiveness Analysis
11. Middle East & Africa Liver Cirrhosis Treatment Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
11.1. Key Highlights
11.2. Historical Market Size (US$ Bn) Analysis, By Market, 2018 - 2022
11.2.1. By Country
11.2.2. By Treatment
11.2.3. By End-use
11.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2023 - 2031
11.3.1. GCC Countries
11.3.2. Egypt
11.3.3. South Africa
11.3.4. Northern Africa
11.3.5. Rest of Middle East & Africa
11.4. Current Market Size (US$ Bn) Analysis and Forecast, By Treatment, 2023 - 2031
11.4.1. Antibiotics
11.4.2. Immunosuppressants
11.4.3. Others
11.5. Current Market Size (US$ Bn) Analysis and Forecast, By End-use, 2023 - 2031
11.5.1. Hospitals
11.5.2. Clinics
11.5.3. Pharmaceutical companies
11.5.4. Research institutions
11.6. Market Attractiveness Analysis
12. Competition Landscape
12.1. Market Share Analysis, 2023
12.2. Market Structure
12.2.1. Competition Intensity Mapping By Market
12.2.2. Competition Dashboard
12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
12.3.1. Merck & Co., Inc.
12.3.1.1. Overview
12.3.1.2. Segments and Products
12.3.1.3. Key Financials
12.3.1.4. Market Developments
12.3.1.5. Market Strategy
12.3.2. AstraZeneca
12.3.2.1. Overview
12.3.2.2. Segments and Products
12.3.2.3. Key Financials
12.3.2.4. Market Developments
12.3.2.5. Market Strategy
12.3.3. Sanofi
12.3.3.1. Overview
12.3.3.2. Segments and Products
12.3.3.3. Key Financials
12.3.3.4. Market Developments
12.3.3.5. Market Strategy
12.3.4. Gilead Sciences, Inc.
12.3.4.1. Overview
12.3.4.2. Segments and Products
12.3.4.3. Key Financials
12.3.4.4. Market Developments
12.3.4.5. Market Strategy
12.3.5. Hoffmann-La Roche Ltd
12.3.5.1. Overview
12.3.5.2. Segments and Products
12.3.5.3. Key Financials
12.3.5.4. Market Developments
12.3.5.5. Market Strategy
12.3.6. Novartis AG
12.3.6.1. Overview
12.3.6.2. Segments and Products
12.3.6.3. Key Financials
12.3.6.4. Market Developments
12.3.6.5. Market Strategy
12.3.7. Bayer AG
12.3.7.1. Overview
12.3.7.2. Segments and Products
12.3.7.3. Key Financials
12.3.7.4. Market Developments
12.3.7.5. Market Strategy
12.3.8. Pfizer, Inc.
12.3.8.1. Overview
12.3.8.2. Segments and Products
12.3.8.3. Key Financials
12.3.8.4. Market Developments
12.3.8.5. Market Strategy
12.3.9. Shionogi Inc.
12.3.9.1. Overview
12.3.9.2. Segments and Products
12.3.9.3. Key Financials
12.3.9.4. Market Developments
12.3.9.5. Market Strategy
12.3.10. Promethera
12.3.10.1. Overview
12.3.10.2. Segments and Products
12.3.10.3. Key Financials
12.3.10.4. Market Developments
12.3.10.5. Market Strategy
12.3.11. AbbVie
12.3.11.1. Overview
12.3.11.2. Segments and Products
12.3.11.3. Key Financials
12.3.11.4. Market Developments
12.3.11.5. Market Strategy
12.3.12. Takeda Pharmaceutical Company Limited
12.3.12.1. Overview
12.3.12.2. Segments and Products
12.3.12.3. Key Financials
12.3.12.4. Market Developments
12.3.12.5. Market Strategy
13. Appendix
13.1. Research Methodology
13.2. Research Assumptions
13.3. Acronyms and Abbreviations
Report Sample is Available
In-depth report coverage is now just a few seconds away
Get FREE Report Sample
Make This Report Your Own
Take Advantage of Intelligence Tailored to your Business Objective
Get a Customized Version
